TMO: Thermo Fisher Scientific Inc. - Summary | Jitta

Thermo Fisher Scientific Inc.

NYSE:TMO

Price
$518.18
Loss Chance
43.2%
7.09JITTA SCORE
16.98%Under Jitta Line
Jitta Ranking
321 / 1,176
2,684 / 5,159
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (54)
Recent Business Performance (34)
Financial Strength (84)
Return to Shareholders (81)
Competitive Advantage (73)
Jitta Signs
Revenue and EarningConsistent High Growth in the past 3 years
Dividend PayoutIncreasing Every Year
CapExVery Low
Interest Coverage RatioVery Good
SG&A to SalesDecreasing Every Year
Operating MarginDeclined
Recent Business PerformanceEarning decline 35.60% in the last quarter (yoy)
Key Stats
Jitta Score
Jitta Line
7.09
16.98%
1.96
201.34%
Life Sciences Tools and Services
7.57
13.95%
6.51
58.17%
3.72
100.00%
COMPANY DESCRIPTION
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company’s Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.